MUSC Hollings opens phase I cancer clinical trials unit

Sarah Bigelow named executive director of Tulane Cancer Center Clinical Trials Office

Sarah Bigelow was named executive director of the Clinical Trials Office at the Tulane Cancer Center.

July 05, 2024

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

Cancer centers that continue to experience pandemic-induced shortages in staffing their clinical research enterprise may soon be able to rely on support from NCI’s Virtual Clinical Trials Office to open studies and accrue patients.

June 28, 2024

Vol.50 No.26

By Matthew Bin Han Ong

White House

At White House forum, Bertagnolli, Califf, Wegrzyn call for greater innovation in clinical trials

Leaders of three health agencies presented new initiatives focused on patient-centered research, diversity in clinical trial enrollment, and innovation in clinical research.

June 28, 2024

Vol.50 No.26

By McKenzie Prillaman

In Brief

Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores

Diane Simeone, director of Moores Cancer Center at UC San Diego Health, has expanded her leadership team.

June 14, 2024

Vol.50 No.24

Obituary

Richard Simon, NCI’s visionary biostatistician, dies at 80

Richard M. Simon, NCI biostatistician who likely set a record for the number of first-authored papers, and whose interests included country music, horseback riding and ballroom dancing, died May 9, at age 80. Simon joined NCI in 1974.

Orserdu combinations show favorable safety profiles for ER+, HER2- metastatic breast cancer in phase Ib/II trials

The Menarini Group and Stemline Therapeutics Inc., a wholly-owned subsidiary of the Menarini Group, will present updated results from phase Ib/II ELECTRA and ELEVATE clinical studies evaluating elacestrant (Orserdu) in combination with other treatments at the 2024 American Society of Clinical Oncology on June 2.

May 24, 2024

Vol.50 No.21

MUSC Hollings opens phase I cancer clinical trials unit

YOU MAY BE INTERESTED IN

Sarah Bigelow named executive director of Tulane Cancer Center Clinical Trials Office

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

At White House forum, Bertagnolli, Califf, Wegrzyn call for greater innovation in clinical trials

Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores

Richard Simon, NCI’s visionary biostatistician, dies at 80

Orserdu combinations show favorable safety profiles for ER+, HER2- metastatic breast cancer in phase Ib/II trials

Renew today!

Subscriber content

Login